155 related articles for article (PubMed ID: 35052009)
1. Neurocoagulation from a Mechanistic Point of View in the Central Nervous System.
Shavit-Stein E; Berkowitz S; Gofrit SG; Altman K; Weinberg N; Maggio N
Semin Thromb Hemost; 2022 Apr; 48(3):277-287. PubMed ID: 35052009
[TBL] [Abstract][Full Text] [Related]
2. Role of thrombin-PAR1-PKCθ/δ axis in brain pericytes in thrombin-induced MMP-9 production and blood-brain barrier dysfunction in vitro.
Machida T; Dohgu S; Takata F; Matsumoto J; Kimura I; Koga M; Nakamoto K; Yamauchi A; Kataoka Y
Neuroscience; 2017 May; 350():146-157. PubMed ID: 28344073
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of modulation of brain microvascular endothelial cells function by thrombin.
Brailoiu E; Shipsky MM; Yan G; Abood ME; Brailoiu GC
Brain Res; 2017 Feb; 1657():167-175. PubMed ID: 27998795
[TBL] [Abstract][Full Text] [Related]
4. Occupancy of human EPCR by protein C induces β-arrestin-2 biased PAR1 signaling by both APC and thrombin.
Roy RV; Ardeshirylajimi A; Dinarvand P; Yang L; Rezaie AR
Blood; 2016 Oct; 128(14):1884-1893. PubMed ID: 27561318
[TBL] [Abstract][Full Text] [Related]
5. Phosphoproteomic analysis of protease-activated receptor-1 biased signaling reveals unique modulators of endothelial barrier function.
Lin Y; Wozniak JM; Grimsey NJ; Girada S; Patwardhan A; Molinar-Inglis O; Smith TH; Lapek JD; Gonzalez DJ; Trejo J
Proc Natl Acad Sci U S A; 2020 Mar; 117(9):5039-5048. PubMed ID: 32071217
[TBL] [Abstract][Full Text] [Related]
6. Protease-activated receptor-1 cleaved at R46 mediates cytoprotective effects.
Schuepbach RA; Madon J; Ender M; Galli P; Riewald M
J Thromb Haemost; 2012 Aug; 10(8):1675-84. PubMed ID: 22712885
[TBL] [Abstract][Full Text] [Related]
7. Integration of endothelial protease-activated receptor-1 inflammatory signaling by ubiquitin.
Grimsey NJ; Trejo J
Curr Opin Hematol; 2016 May; 23(3):274-9. PubMed ID: 26845544
[TBL] [Abstract][Full Text] [Related]
8. Protection of vascular barrier integrity by activated protein C in murine models depends on protease-activated receptor-1.
Schuepbach RA; Feistritzer C; Fernández JA; Griffin JH; Riewald M
Thromb Haemost; 2009 Apr; 101(4):724-33. PubMed ID: 19350118
[TBL] [Abstract][Full Text] [Related]
9. Protease-activated receptor-1 signaling by activated protein C in cytokine-perturbed endothelial cells is distinct from thrombin signaling.
Riewald M; Ruf W
J Biol Chem; 2005 May; 280(20):19808-14. PubMed ID: 15769747
[TBL] [Abstract][Full Text] [Related]
10. A New Concept of Action of Hemostatic Proteases on Inflammation, Neurotoxicity, and Tissue Regeneration.
Gorbacheva LR; Kiseleva EV; Savinkova IG; Strukova SM
Biochemistry (Mosc); 2017 Jul; 82(7):778-790. PubMed ID: 28918742
[TBL] [Abstract][Full Text] [Related]
11. Systemic thrombin inhibition ameliorates seizures in a mouse model of pilocarpine-induced status epilepticus.
Lenz M; Shimon MB; Benninger F; Neufeld MY; Shavit-Stein E; Vlachos A; Maggio N
J Mol Med (Berl); 2019 Nov; 97(11):1567-1574. PubMed ID: 31667526
[TBL] [Abstract][Full Text] [Related]
12. Contribution of protease-activated receptor 1 in status epilepticus-induced epileptogenesis.
Isaev D; Lushnikova I; Lunko O; Zapukhliak O; Maximyuk O; Romanov A; Skibo GG; Tian C; Holmes GL; Isaeva E
Neurobiol Dis; 2015 Jun; 78():68-76. PubMed ID: 25843668
[TBL] [Abstract][Full Text] [Related]
13. Brain pericytes are the most thrombin-sensitive matrix metalloproteinase-9-releasing cell type constituting the blood-brain barrier in vitro.
Machida T; Takata F; Matsumoto J; Takenoshita H; Kimura I; Yamauchi A; Dohgu S; Kataoka Y
Neurosci Lett; 2015 Jul; 599():109-14. PubMed ID: 26002077
[TBL] [Abstract][Full Text] [Related]
14. Activated protein C promotes protease-activated receptor-1 cytoprotective signaling through β-arrestin and dishevelled-2 scaffolds.
Soh UJ; Trejo J
Proc Natl Acad Sci U S A; 2011 Dec; 108(50):E1372-80. PubMed ID: 22106258
[TBL] [Abstract][Full Text] [Related]
15. Biased agonism of protease-activated receptor-1 regulates thromboinflammation in murine sickle cell disease.
Ramadas N; Lowder K; Dutton J; Trebak F; Faes C; Griffin JH; Pawlinski R; Mosnier LO; Sparkenbaugh E
Blood Adv; 2024 Jun; 8(12):3272-3283. PubMed ID: 38640339
[TBL] [Abstract][Full Text] [Related]
16. The anticoagulant activated protein C (aPC) promotes metaplasticity in the hippocampus through an EPCR-PAR1-S1P1 receptors dependent mechanism.
Maggio N; Itsekson Z; Ikenberg B; Strehl A; Vlachos A; Blatt I; Tanne D; Chapman J
Hippocampus; 2014 Aug; 24(8):1030-8. PubMed ID: 24753100
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the thrombin/protease-activated receptor 1 axis by chemokine (C
Gao X; Cheng YH; Enten GA; DeSantis AJ; Gaponenko V; Majetschak M
J Biol Chem; 2020 Oct; 295(44):14893-14905. PubMed ID: 32839271
[TBL] [Abstract][Full Text] [Related]
18. Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation.
Feistritzer C; Riewald M
Blood; 2005 Apr; 105(8):3178-84. PubMed ID: 15626732
[TBL] [Abstract][Full Text] [Related]
19. Activated protein C-cleaved protease activated receptor-1 is retained on the endothelial cell surface even in the presence of thrombin.
Schuepbach RA; Feistritzer C; Brass LF; Riewald M
Blood; 2008 Mar; 111(5):2667-73. PubMed ID: 18089851
[TBL] [Abstract][Full Text] [Related]
20. FVIIa (Factor VIIa) Induces Biased Cytoprotective Signaling in Mice Through the Cleavage of PAR (Protease-Activated Receptor)-1 at Canonical Arg41 (Arginine41) Site.
Kondreddy V; Pendurthi UR; Xu X; Griffin JH; Rao LVM
Arterioscler Thromb Vasc Biol; 2020 May; 40(5):1275-1288. PubMed ID: 32212848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
